The Performance of Acute Peritoneal Dialysis Treatment in Neonatal Period


Alparslan C., Yavascan O., Bal A., Kanik A., Kose E., Demir B. K., ...Daha Fazla

RENAL FAILURE, cilt.34, sa.8, ss.1015-1020, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 34 Sayı: 8
  • Basım Tarihi: 2012
  • Doi Numarası: 10.3109/0886022x.2012.708378
  • Dergi Adı: RENAL FAILURE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1015-1020
  • Anahtar Kelimeler: acute kidney injury, neonatal period, peritoneal dialysis, intensive care unit, treatment, INBORN-ERRORS, RENAL-FAILURE, CHILDREN
  • Ankara Üniversitesi Adresli: Hayır

Özet

The aim of this retrospective study was to evaluate our neonatal intensive care unit (NICU) patients' characteristics treated with acute peritoneal dialysis (PD) and their risk factors for mortality. We also wanted to share our experience of the application of PD in neonates who required less than 60 mL of dwell volume and their PD-related problems, as well as special solutions for these problems. This study included 27 infants treated in our NICU between February 2008 and December 2011. We retrospectively analyzed these patients' records. The percutaneous PD catheter was placed by us. PD procedure was performed either by manual technique or automated PD. Statistical evaluation was performed by using chi(2)-tests and Student's t-tests. In these 27 neonates, the average gestational age and birth weight were 35.18 +/- 4.02 weeks and 2534.62 +/- 897.41 g, respectively. The mean PD duration time was 6.11 +/- 6.30 days. Of these, 10 patients were treated by manual technique, whereas 17 patients were treated with automated system. Among 27 neonates, 16 patients died. Overall mortality rate was 59.25%. PD-related complications were seen in 25.92% of patients. In conclusion, PD application is less effective and troublesome for low-birth-weight infants. Each center should create its own solutions to accommodate problematic patients in PD treatment to improve the outcome in this special population.